While the oncogenic roles of UBE2N and tumor-derived EVs have been previously reported [11,35], our work is the first to demonstrate a functional role for UBE2NL and HIST2H3PS2, particularly in the context of EV-mediated tumor progression in gynecologic cancers. The gene discussed is UBE2N; the disease is female reproductive organ cancer.